Use of amphotericin B with azole antifungal drugs: what are we doing?
- 1 September 1995
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (9) , 1907-1912
- https://doi.org/10.1128/aac.39.9.1907
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Combination Therapy in Experimental Invasive AspergillosisThe Journal of Infectious Diseases, 1993
- Effects of 1-(Halogenalkoxy)Alkyl-5-Fluorouracil Derivatives on Cell Growth, Cell Volume and Nucleus Size of Mouse Lymphoma CellsChemotherapy, 1992
- Combination therapy in a model of pulmonary aspergillosisMycoses, 1991
- Interactions in vitro between polyenes and imidazoles against yeastsJournal of Antimicrobial Chemotherapy, 1991
- Combination Therapy of Experimental Candidiasis, Cryptococcosis, Aspergillosis and Wangiellosis in MiceChemotherapy, 1987
- The Effect of Ketoconazole on Amphotericin B in a Model of Disseminated AspergillosisThe Journal of Infectious Diseases, 1985
- Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis ModelThe Journal of Infectious Diseases, 1983
- In Vitro Veritas? Antimicrobial Susceptibility Tests and Their Clinical RelevanceThe Journal of Infectious Diseases, 1981
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979